16. Which symptoms are NOT included in the evaluation of the severity of alcohol withdrawal? a. Headache. b. Tremor. c. Anxiety. d. Diarrhea. 17. Which medication is indicated to treat both alcohol and opioid use disorder? a. Buprenorphine. b. Naltrexone. c. Disulfuram. d. Acamprosate. 18. Benzodiazepines are commonly used to treat the following conditions EXCEPT: a. Anxiety. b. Tourette's Syndrome. c. Dementia. d. Insomnia. 19. All the following drugs are considered stimulants EXCEPT: a. Mescaline (peyote). b. MDMA/ Ecstacy. c. Bath Salts. d. Cocaine. 20. State-wide Prescription Drug Monitoring Programs: a. Alert physicians when their medical license is associated with a controlled substance prescription.. b. Include Schedule 1 substance prescriptions.. c. Included those substances utilized in the in- patient hospital setting.. d. Frequently share data with other states.. 21. Naloxone: a. Is a strong opioid agonist. b. May precipitate acute withdrawal. c. Can lead to dangerous complications in the patient with altered mental status un-related to opioids. d. is available only by prescription. 22. Side effects of opioid medications include the following: a. Respiratory depression. b. Pruritis. c. Constipation. d. All of the above. 23. The Opioid with the highest Morphine Milligram Equivalent (MME) listed below is: a. Codeine. b. Tramadol. c. Diazepam. d. Fentanyl. 24. The MME (Morphine Milligram Equivalent) per day limit that typically requires justification to states and insurance payers before approval is:
25. Benefits of using buprenorphine in the treatment of OUD include: a. Ease of administration. b. Low risk for respiratory depression. c. Ability to use protocol dosing using the COWS (Clinical Opiate Withdrawal Scale). d. All of the above. 26. The number of lives lost to drug overdose in 2021 was found to be a. About 10,000 lives. b. About 30,000 lives. c. Just under 70,000 lives. d. Over 100,000 lives. 27. Buprenorphine is an opioid __________. a. Full agonist. b. Partial agonist. c. Antagonist. d. Receptor Type. 28. Regarding opioid use disorder: a. Physical dependency can develop after 2-10 days of continuous use. b. Opioid related overdose death is largely attributed to fentanyl. c. Can be associated with biological and environmental factors. d. All of the above. 29. The following patient education topics should be discussed with patients who are prescribed opioid medications. a. Education regarding the use of naloxone (Narcan). b. Secure storage of the drug. c. Proper disposal of the drug. d. All of the above. 30. The prevalence of substance use disorder (SUD) in physicians is estimated to be about:
a. 10%. b. 20%. c. 30%. d. 40%
a. 25 MME/Day. b. 40 MME/Day. c. 75 MME/Day. d. 90 MME/Day.
Course Code: MDCO08SD
Book Code: MDCO1025
Page 85
Powered by FlippingBook